PubRank

Robert L Davis

Author PubWeight™ 84.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prescription drug use in pregnancy. Am J Obstet Gynecol 2004 4.92
2 Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007 4.16
3 Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006 3.61
4 Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002 3.07
5 Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst 2012 2.21
6 Potential medication dosing errors in outpatient pediatrics. J Pediatr 2005 2.19
7 Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004 1.89
8 FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf 2006 1.83
9 Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 2006 1.73
10 Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 2007 1.66
11 Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care 2006 1.60
12 Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003 1.58
13 Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004 1.55
14 Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt) 2014 1.54
15 Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005 1.46
16 Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2009 1.38
17 Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003 1.36
18 Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 2007 1.35
19 Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst 2010 1.30
20 Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA 2006 1.26
21 Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med 2005 1.23
22 Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc 2005 1.22
23 Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf 2012 1.20
24 Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis 2013 1.20
25 Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev 2012 1.15
26 Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 2010 1.09
27 Medication Exposure in Pregnancy Risk Evaluation Program. Matern Child Health J 2012 1.08
28 Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med 2004 1.08
29 Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf 2007 1.04
30 Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health 2013 1.03
31 Use of a respiratory clinical score among different providers. Pediatr Pulmonol 2004 1.03
32 Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care 2014 1.01
33 Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics 2006 1.01
34 Predictors of incident heart failure in a large insured population: a one million person-year follow-up study. Circ Heart Fail 2010 1.00
35 Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc 2015 0.98
36 Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study. Paediatr Perinat Epidemiol 2012 0.96
37 Compliance with national immunization guidelines for children younger than 2 years, 1996-1999. Pediatrics 2005 0.95
38 Using the Bayesian Improved Surname Geocoding Method (BISG) to create a working classification of race and ethnicity in a diverse managed care population: a validation study. Health Serv Res 2013 0.92
39 Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf 2013 0.90
40 Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc 2005 0.90
41 Hepatitis B vaccination among adolescents in 3 large health maintenance organizations. Pediatrics 2002 0.90
42 KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo. Mol Cancer Ther 2008 0.90
43 Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol 2013 0.87
44 Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005. Vaccine 2009 0.86
45 The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics 2012 0.86
46 Synthesis and SAR of thiophene containing kinesin spindle protein (KSP) inhibitors. Bioorg Med Chem Lett 2007 0.85
47 Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf 2013 0.85
48 Administrative data used to identify patients with irritable bowel syndrome. J Clin Epidemiol 2008 0.85
49 Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003. Vaccine 2008 0.85
50 Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf 2009 0.84
51 Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2004 0.84
52 Childhood vaccinations and risk of asthma. Pediatr Infect Dis J 2002 0.82
53 A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis 2012 0.82
54 The utility of claims data for infection surveillance following anterior cruciate ligament reconstruction. Infect Control Hosp Epidemiol 2014 0.80
55 Polio extraimmunization in children younger than 2 years after changes in immunization recommendations. Pediatrics 2003 0.80
56 Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf 2007 0.79
57 A simulation study to compare three self-controlled case series approaches: correction for violation of assumption and evaluation of bias. Pharmacoepidemiol Drug Saf 2013 0.79
58 Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual. Pharmacoepidemiol Drug Saf 2013 0.79
59 Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf 2013 0.79
60 The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007. Matern Child Health J 2014 0.78
61 Is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine? J Infect Dis 2006 0.78
62 Barriers to implementing the group B streptococcal prevention guidelines. Birth 2002 0.77
63 Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study. Pharmacoepidemiol Drug Saf 2007 0.77
64 Pneumococcal conjugate vaccine in children. N Engl J Med 2004 0.75
65 Risk of congenital malformations among infants exposed to antidepressants during pregnancy. Pharmacoepidemiol Drug Saf 2008 0.75
66 Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model. Vet Dermatol 2009 0.75
67 Re: "genetic susceptibility to severe infection in families with invasive pneumococcal disease". Am J Epidemiol 2008 0.75
68 Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic. Pharmaceutics 2013 0.75
69 Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2011 0.75
70 In nonrandomized studies, can we use a person's preimmunization experience to help gauge the safety and efficacy of immunization? Am J Epidemiol 2002 0.75
71 Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective and subjective measures of health, comfort, and vision. Eye Contact Lens 2013 0.75
72 Intussusception and oral poliovirus vaccination: is there an association? Am J Epidemiol 2004 0.75